SEC Form 4 · accession 0001193805-26-000892
IMMUNIC, INC. · IMUX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon Congleton
Director
Period of report
Jun 29, 2026
Accepted (ET)
Jun 29, 2026 · 4:34 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001280776
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F2 | $10.90 | Jun 29, 2026 | A | 50,740 | A | — | Mar 27, 2036 | Common Stock | 50,740 | 50,740 | D |
Explanation of responses
- F1Represents options to purchase shares of common stock conditionally approved by the Board of Directors on March 27, 2026, subject to approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, as amended, by the Company's stockholders, which approval was obtained at the Company's 2026 Annual Meeting of Stockholders held on June 29, 2026.
- F2The options vest in thirty-six (36) equal installments on each monthly anniversary of March 27, 2026.